Caspofungin Labatec 50 mg
Caspofungin Labatec 50 mg is a medicine authorised by Swissmedic under authorisation number 68433. The authorisation holder is Labatec Pharma SA. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 16 June 2022 and the authorisation is limited until 15 June 2027. ATC code J02AX04 places the medicine in the group Antimycotics for systemic use.
| Authorisation number | 68433 |
|---|---|
| Name | Caspofungin Labatec 50 mg |
| Full name | Caspofungin Labatec 50 mg, Poudre pour solution à diluer pour perfusion |
| Authorisation holder | Labatec Pharma SA |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | J02AX04 |
| First authorisation | 16 June 2022 |
| Authorisation validity | 15 June 2027 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Caspofungin Labatec 50 mg, Poudre pour solution à diluer pour perfusion | A | 16 June 2022 |
| 2 | Caspofungin Labatec 70 mg, Poudre pour solution à diluer pour perfusion | A | 16 June 2022 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Durchstechflasche(n) | J02AX04 | 08.06.0. | A |
| 2 | 1 | Durchstechflasche(n) | J02AX04 | 08.06.0. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Caspofungin Labatec 50 mg authorised in Switzerland?
Yes. Caspofungin Labatec 50 mg is authorised by Swissmedic under authorisation number 68433, data as of 01 September 2026. The authorisation is limited until 15 June 2027.
Which dispensing category does Caspofungin Labatec 50 mg have?
Caspofungin Labatec 50 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Caspofungin Labatec 50 mg?
The authorisation holder is Labatec Pharma SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.